Abstract
The ICF syndrome is a rare, autosomal recessive disorder, often fatal in childhood, and characterized by genetic and clinical heterogeneity. Its most consistent features are reduction in serum immunoglobulin levels, facial anomalies, and cytogenetic defects. ICF is also characterized by abnormal DNA methylation. Significant DNA hypomethylation is present mainly in the classical satellite sequences, the major constituent of the juxtacentromeric heterochromatin of chromosomes 1, 9, and 16. The relationship between DNA methylation defects, altered gene expression, and clinical and phenotypic features in ICF has been the object of intense scrutiny. Although the full pathogenetic picture remains to be elucidated, a number of hypotheses advocating an epigenetic model for this syndrome have been advanced by different research groups. Central to some of these hypotheses is the postulation of a trans-acting regulatory role for the heterochromatin and the suggestion of a possible connection between altered gene expression in ICF and the inappropriate release or recruitment of regulatory complexes by the hypomethylated satellite DNA. This chapter reviews the evidence supporting an association between pathology, large-scale chromatin organization, and nuclear architecture in this enigmatic syndrome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aran D et al (2011) Replication timing-related and gene body-specific methylation of active human genes. Hum Mol Genet 20(4):670–680
Bachman KE, Rountree MR, Baylin SB (2001) Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem 276(34):32282–32287
Barki-Celli L et al (2005) Differences in nuclear positioning of 1q12 pericentric heterochromatin in normal and tumor B lymphocytes with 1q rearrangements. Genes Chromosomes Cancer 43(4):339–349
Bartova E et al (2002) Nuclear structure and gene activity in human differentiated cells. J Struct Biol 139(2):76–89
Bickmore WA, van der Maarel SM (2003) Perturbations of chromatin structure in human genetic disease: recent advances. Hum Mol Genet 2:5
Bourc’his D et al (1999) Abnormal methylation does not prevent X inactivation in ICF patients. Cytogenet Cell Genet 84(3–4):245–252
Brown DC et al (1995) ICF syndrome (immunodeficiency, centromeric instability and facial anomalies): investigation of heterochromatin abnormalities and review of clinical outcome. Hum Genet 96(4):411–416
Brown KE et al (1997) Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell 91(6):845–854
Brown KE et al (1999) Dynamic repositioning of genes in the nucleus of lymphocytes preparing for cell division. Mol Cell 3(2):207–217
Brun ME et al (2011) Heterochromatic genes undergo epigenetic changes and escape silencing in immunodeficiency, centromeric instability, facial anomalies (ICF) syndrome. PLoS One 6(4):e19464
Chouery E et al (2012) A novel deletion in ZBTB24 in a Lebanese family with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Clin Genet 82(5):489–493
Croft JA et al (1999) Differences in the localization and morphology of chromosomes in the human nucleus. J Cell Biol 145(6):1119–1131
de Greef JC et al (2011) Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2. Am J Hum Genet 88(6):796–804
Dupont C et al (2012) 3D position of pericentromeric heterochromatin within the nucleus of a patient with ICF syndrome. Clin Genet 82(2):187–192
Ehrlich M (2003) The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease. Clin Immunol 109(1):17–28
Ehrlich M (2009) DNA hypomethylation in cancer cells. Epigenomics 1(2):239–259
Ehrlich M et al (2001) DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes. Hum Mol Genet 10(25):2917–2931
Ehrlich M, Jackson K, Weemaes C (2006) Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF). Orphanet J Rare Dis 1:2
Ehrlich M et al (2008) ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation. Autoimmunity 41(4):253–271
Feng J, Fan G (2009) The role of DNA methylation in the central nervous system and neuropsychiatric disorders. Int Rev Neurobiol 89:67–84
Ferreira J et al (1997) Spatial organization of large-scale chromatin domains in the nucleus: a magnified view of single chromosome territories. J Cell Biol 139(7):1597–1610
Francastel C et al (1999) A functional enhancer suppresses silencing of a transgene and prevents its localization close to centromeric heterochromatin. Cell 99(3):259–269
Francastel C, Magis W, Groudine M (2001) Nuclear relocation of a transactivator subunit precedes target gene activation. Proc Natl Acad Sci U S A 98(21):12120–12125
Geiman TM et al (2004) DNMT3B interacts with hSNF2H chromatin remodeling enzyme, HDACs 1 and 2, and components of the histone methylation system. Biochem Biophys Res Commun 318(2):544–555
Gimelli G et al (1993) ICF syndrome with variable expression in sibs. J Med Genet 30(5):429–432
Gisselsson D et al (2005) Interphase chromosomal abnormalities and mitotic missegregation of hypomethylated sequences in ICF syndrome cells. Chromosoma (Berl) 114(2):118–126
Gopalakrishnan S et al (2009) DNMT3B interacts with constitutive centromere protein CENP-C to modulate DNA methylation and the histone code at centromeric regions. Hum Mol Genet 18(17):3178–3193
Grogan JL et al (2001) Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14(3):205–215
Hagleitner MM et al (2008) Clinical spectrum of immunodeficiency, centromeric instability and facial dysmorphism (ICF syndrome). J Med Genet 45(2):93–99
Hansen RS et al (1999) The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci U S A 96(25):14412–14417
Hansen RS et al (2000) Escape from gene silencing in ICF syndrome: evidence for advanced replication time as a major determinant. Hum Mol Genet 9(18):2575–2587
Hassan KM et al (2001) Satellite 2 methylation patterns in normal and ICF syndrome cells and association of hypomethylation with advanced replication. Hum Genet 109(4):452–462
Heidari M et al (2006) The nuclear oncoprotein TLX1/HOX11 associates with pericentromeric satellite 2 DNA in leukemic T-cells. Leukemia 20(2):304–312
Heyn H et al (2012) Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patient. Epigenetics 7:6
Jeanpierre M et al (1993) An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. Hum Mol Genet 2(6):731–735
Jefferson A et al (2010) Altered intra-nuclear organisation of heterochromatin and genes in ICF syndrome. PLoS One 5(6):e11364
Ji W et al (1997) DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutat Res 379(1):33–41
Jiang YL et al (2005) DNMT3B mutations and DNA methylation defect define two types of ICF syndrome. Hum Mutat 25(1):56–63
Jin B et al (2008) DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. Hum Mol Genet 17(5):690–709
Kondo T et al (2000) Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. Hum Mol Genet 9(4):597–604
Kubota T et al (2004) ICF syndrome in a girl with DNA hypomethylation but without detectable DNMT3B mutation. Am J Med Genet A 1(3):290–293
Lana E et al (2012) DNA replication is altered in immunodeficiency centromeric instability facial anomalies (ICF) cells carrying DNMT3B mutations. Eur J Hum Genet 29(10):41
Luciani JJ et al (2005) Subcellular distribution of HP1 proteins is altered in ICF syndrome. Eur J Hum Genet 13(1):41–51
Luciani JJ et al (2006) PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase. J Cell Sci 119(pt 12):2518–2531
Maraschio P et al (1988) Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9, and 16, and facial anomalies: the ICF syndrome. J Med Genet 25(3):173–180
Maraschio P et al (1989) Differential expression of the ICF (immunodeficiency, centromeric heterochromatin, facial anomalies) mutation in lymphocytes and fibroblasts. J Med Genet 26(7):452–456
Maraschio P et al (1992) Interphase cytogenetics of the ICF syndrome. Ann Hum Genet 56(pt 3):273–278
Martins-Taylor K et al (2012) Role of DNMT3B in the regulation of early neural and neural crest specifiers. Epigenetics 7:1
Matarazzo MR et al (2007) Chromosome territory reorganization in a human disease with altered DNA methylation. Proc Natl Acad Sci U S A 104(42):16546–16551
Miniou P et al (1994) Abnormal methylation pattern in constitutive and facultative (X inactive chromosome) heterochromatin of ICF patients. Hum Mol Genet 3(12):2093–2102
Miniou P et al (1997a) Alpha-satellite DNA methylation in normal individuals and in ICF patients: heterogeneous methylation of constitutive heterochromatin in adult and fetal tissues. Hum Genet 99(6):738–745
Miniou P et al (1997b) Undermethylation of Alu sequences in ICF syndrome: molecular and in situ analysis. Cytogenet Cell Genet 77(3–4):308–313
Misteli T (2004) Spatial positioning; a new dimension in genome function. Cell 119(2):153–156
Okano M et al (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99(3):247–257
Prada D et al (2012) Satellite 2 demethylation induced by 5-azacytidine is associated with missegregation of chromosomes 1 and 16 in human somatic cells. Mutat Res 729(1–2):100–105
Ragoczy T et al (2003) A genetic analysis of chromosome territory looping: diverse roles for distal regulatory elements. Chromosome Res 11(5):513–525
Roldan E et al (2005) Locus ‘decontraction’ and centromeric recruitment contribute to allelic exclusion of the immunoglobulin heavy-chain gene. Nat Immunol 6(1):31–41
Sadoni N et al (1999) Nuclear organization of mammalian genomes. Polar chromosome territories build up functionally distinct higher order compartments. J Cell Biol 146(6):1211–1226
Saurin AJ et al (1998) The human polycomb group complex associates with pericentromeric heterochromatin to form a novel nuclear domain. J Cell Biol 142(4):887–898
Sawyer JR et al (1995a) Chromosome instability in ICF syndrome: formation of micronuclei from multibranched chromosomes 1 demonstrated by fluorescence in situ hybridization. Am J Med Genet 56(2):203–209
Sawyer JR et al (1995b) Centromeric instability of chromosome 1 resulting in multibranched chromosomes, telomeric fusions, and “jumping translocations” of 1q in a human immunodeficiency virus-related non-Hodgkin’s lymphoma. Cancer (Phila) 76(7):1238–1244
Scheuermann MO et al (2004) Topology of genes and nontranscribed sequences in human interphase nuclei. Exp Cell Res 301(2):266–279
Schubeler D et al (2000) Nuclear localization and histone acetylation: a pathway for chromatin opening and transcriptional activation of the human beta-globin loc.s. Genes Dev 14(8):940–950
Schuffenhauer S et al (1995) DNA, FISH and complementation studies in ICF syndrome: DNA hypomethylation of repetitive and single copy loci and evidence for a trans acting factor. Hum Genet 96(5):562–571
Shopland LS et al (2006) Folding and organization of a contiguous chromosome region according to the gene distribution pattern in primary genomic sequence. J Cell Biol 174(1):27–38
Stacey M, Bennett MS, Hulten M (1995) FISH analysis on spontaneously arising micronuclei in the ICF syndrome. J Med Genet 32(7):502–508
Sumner AT, Mitchell AR, Ellis PM (1998) A FISH study of chromosome fusion in the ICF syndrome: involvement of paracentric heterochromatin but not of the centromeres themselves. J Med Genet 35(10):833–835
Tanabe H et al (2002) Non-random radial arrangements of interphase chromosome territories: evolutionary considerations and functional implications. Mutat Res 504(1–2):37–45
Toyota M, Suzuki H (2010) Epigenetic drivers of genetic alterations. Adv Genet 70:309–323
Tuck-Muller CM et al (2000) DNA hypomethylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogenet Cell Genet 89(1–2):121–128
Ueda Y et al (2006) Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome. Development (Camb) 133(6):1183–1192
van den Brand M et al (2011) Angiosarcoma in a patient with immunodeficiency, centromeric region instability, facial anomalies (ICF) syndrome. Am J Med Genet A 3:622–625
Volpi EV, Bridger JM (2008) FISH glossary: an overview of the fluorescence in situ hybridization technique. Biotechniques 45(4):385–386, 388, 390, passim
Wijmenga C et al (1998) Localization of the ICF syndrome to chromosome 20 by homozygosity mapping. Am J Hum Genet 63(3):803–809
Wijmenga C et al (2000) Genetic variation in ICF syndrome: evidence for genetic heterogeneity. Hum Mutat 16(6):509–517
Xu GL et al (1999) Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature (Lond) 402(6758):187–191
Yehezkel S et al (2008) Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions. Hum Mol Genet 17(18):2776–2789
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Volpi, E.V. (2013). Chromosomes and Nuclear Organization in ICF Syndrome. In: Yurov, Y., Vorsanova, S., Iourov, I. (eds) Human Interphase Chromosomes. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6558-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6558-4_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6557-7
Online ISBN: 978-1-4614-6558-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)